In detail, when NSCLC patients have the T790M and C797S mutations on the same allele (cis-mutations), they experience resistance to all available generations of EGFR-TKIs as a single agent or combined with other drugs [104,105]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.